We provide a complete pipeline from primary progenitor cell selection and positive monocyte isolation to high-sensitivity multiplexed cytokine detection and downstream systems biology analysis for your drug candidates.
To rigorously evaluate candidate bioactivity and safety, Creative Biolabs utilizes a highly sophisticated, primary human macrophage culture system. This service delivers deep profiling of cytokine release, intracellular trafficking pathways, and polarization networks, bypassing the limitations of immortalized cell lines. By partnering with us, your program gains clear quantification of exocytosis pathways to resolve precise mechanisms of action, early identification of hyperinflammatory risks, and high-quality, research-ready datasets generated from primary human donor cohorts to support your preclinical development decisions with complete scientific confidence.
Macrophages drive critical decisions in therapeutic efficacy, shifting between classically activated pro-inflammatory and alternatively activated anti-inflammatory phenotypes. Research highlights their role in hyperinflammatory responses, driven by specific signaling feedback loops, and pathogen-induced immune silencing where protective markers are suppressed. Furthermore, systems biology reveals macrophages express a vast spectrum of cytokine-induced polarization states rather than simple binary profiles. Creative Biolabs' profiling service delivers the physiologically relevant data necessary to navigate this complex biological landscape.
Fig.1 Modulation of macrophage cytokine secretion. 1
We provide a complete pipeline from primary progenitor cell selection and positive monocyte isolation to high-sensitivity multiplexed cytokine detection and downstream systems biology analysis for your drug candidates.
Our team delivers highly customized assay designs tailored to your candidate's unique pharmacology, incorporating specialized multi-point concentration ranges, target co-stimulants, and customized positive or negative control setups.
We utilize physiologically relevant primary human cells differentiated from fully characterized healthy or diseased donor PBMCs, avoiding the abnormal karyotypes and altered signaling kinetics of cheap immortalized lines.
Our specialized assays dissect intracellular trafficking mechanisms, identifying if your candidate induces a post-translational secretory blockade at the level of the endoplasmic reticulum, Golgi, or vesicle docking machinery.
By replacing immortalized lines with primary human cells, we bypass genomic instability and altered signaling kinetics, delivering realistic experimental results that accurately mirror human biology.
Our well-characterized repository of healthy and disease-state donors lets researchers capture real-world immunological diversity, ensuring your candidate's response is robust, reproducible, and representative across populations.
We identify whether your molecule induces an intracellular blockade by resolving how it affects secretory pathways, pinpointing the precise secretory mechanism of action.
Our pipelines project your compound's footprint against global reference databases, classifying its precise functional influence across numerous newly identified, multi-dimensional immune activation pathways.
Get a Quote Today to design a custom testing program that aligns with your research goals.
Can your assay distinguish between a compound that inhibits cytokine transcription and one that blocks secretory trafficking?
Yes. By combining cellular protein analysis with multiplexed supernatant detection, we can determine if your compound causes an exocytic blockade inside the cell or blocks upstream transcription and translation.
How does Creative Biolabs handle donor-to-donor variability inherent in primary human cell assays?
We utilize highly characterized mononuclear cells from a diverse, documented pool of healthy and research-state donors. Every study incorporates multi-donor cohorts and applies robust statistical normalization across datasets to ensure that your candidate's observed biological effect is reproducible.
Evaluate the potential of your therapeutic candidates to trigger unwanted innate immune reactions using our specialized primary human macrophage assays, helping you identify and mitigate safety risks early in development.
Learn More →Profile polarization states and surface marker expressions in your macrophage cultures. Our screening platform tracks phenotypic shifts to characterize how your compounds modulate functional myeloid activation.
Learn More →Creative Biolabs facilitates candidate de-risking and validation by integrating primary human cell models, high-sensitivity assays, and systems-level bioinformatics. This service yields robust, quantitative profiling of diverse macrophage states, enabling researchers to predict hyperinflammatory hazards, evaluate myeloid reactivation, or track phenotypic repolarization.
To initiate collaboration, our immunology specialists assist in customizing assay designs, aligning with specific biomarker strategies, donor specifications, and research timelines, please reach out to our team.
Reference